Transcriptomic Analysis of Pancreatic Cancer Cells in Response to Metformin and Aspirin: an Implication of Synergy

Overview

Journal Sci Rep

Specialty Science

Date 2015 Aug 22

PMID 26294325

Citations 24

Authors

Wen Yue

Tao Wang

Emmanuel Zachariah

Yong Lin

Chung S Yang

Qing Xu

Robert S DiPaola

Xiang-Lin Tan

Affiliations

Soon will be listed here.

Abstract

Metformin and aspirin have been studied extensively as cancer preventative and therapeutic agents. However, the underlying molecular mechanisms for the inhibitory effects of pancreatic cancer development remain undefined. To gain further insight into their biological function in pancreatic cancer, we conducted a transcriptomic analysis using RNA sequencing to assess the differential gene expression induced by metformin (5 mM) and aspirin (2 mM), alone or in combination, after treatment of PANC-1 cells for 48 hours. Compared to an untreated control, metformin down-regulated 58 genes and up-regulated 91 genes, aspirin down-regulated 12 genes only, while metformin plus aspirin down-regulated 656 genes and up-regulated 449 genes (fold-change > 2, P < 10(-5)). Of the top 10 genes (fold-change > 10, P < 10(-10)) regulated by metformin plus aspirin, PCDH18, CCL2, RASL11A, FAM111B and BMP5 were down-regulated ≥ 20-fold, while NGFR, NPTX1, C7orf57, MRPL23AS1 and UNC5B were up-regulated ≥ 10-fold. Ingenuity Pathway Analysis (IPA) revealed that the pathways, "cholesterol biosynthesis", "cell cycle: G1/S checkpoint regulation", and "axonal guidance signaling" were the most statistically significant pathways modulated by metformin plus aspirin. Although the results need further functional validation, these data provide the first evidence for the synergistic action between metformin and aspirin in modulating the transcriptional profile of pancreatic cancer cells.

Citing Articles

Loss of FAM111B protease mutated in hereditary fibrosing poikiloderma negatively regulates telomere length.

Kliszczak M, Moralli D, Jankowska J, Bryjka P, Subha Meem L, Goncalves T Front Cell Dev Biol. 2023; 11:1175069.

PMID: 37342232 PMC: 10277729. DOI: 10.3389/fcell.2023.1175069.

Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.

Gong Q, Dong Q, Zhong B, Zhang T, Cao D, Zhang Y J Clin Lab Anal. 2022; 36(12):e24784.

PMID: 36408702 PMC: 9756984. DOI: 10.1002/jcla.24784.

Is IIIG9 a New Protein with Exclusive Ciliary Function? Analysis of Its Potential Role in Cancer and Other Pathologies.

Oviedo M, Ramirez E, Cifuentes M, Farkas C, Mella A, Bertinat R Cells. 2022; 11(20).

PMID: 36291193 PMC: 9600092. DOI: 10.3390/cells11203327.

NPTX1 inhibits pancreatic cancer cell proliferation and migration and enhances chemotherapy sensitivity by targeting RBM10.

Wu J, Liu G, An K, Shi L Oncol Lett. 2022; 23(5):154.

PMID: 35836482 PMC: 9258595. DOI: 10.3892/ol.2022.13275.

An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer.

Miyaki C, Lynch L Cureus. 2022; 14(5):e25496.

PMID: 35800820 PMC: 9246430. DOI: 10.7759/cureus.25496.

References

Wang Z, Gerstein M, Snyder M . RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2008; 10(1):57-63. PMC: 2949280. DOI: 10.1038/nrg2484. View

Din F, Valanciute A, Houde V, Zibrova D, Green K, Sakamoto K . Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012; 142(7):1504-15.e3. PMC: 3682211. DOI: 10.1053/j.gastro.2012.02.050. View

Rehman M, Tamagnone L . Semaphorins in cancer: biological mechanisms and therapeutic approaches. Semin Cell Dev Biol. 2012; 24(3):179-89. DOI: 10.1016/j.semcdb.2012.10.005. View

Okochi-Takada E, Hattori N, Tsukamoto T, Miyamoto K, Ando T, Ito S . ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis. Oncogene. 2013; 33(17):2273-8. DOI: 10.1038/onc.2013.174. View

Tanaka S, Pero S, Taguchi K, Shimada M, Mori M, Krag D . Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst. 2006; 98(7):491-8. DOI: 10.1093/jnci/djj105. View

Deng X, Wang S, Deng A, Liu B, Edgerton S, Lind S . Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle. 2011; 11(2):367-76. DOI: 10.4161/cc.11.2.18813. View

Mulligan L . RET revisited: expanding the oncogenic portfolio. Nat Rev Cancer. 2014; 14(3):173-86. DOI: 10.1038/nrc3680. View

Wang W, Zhao H, Kang E, Chen Y, Ni C, Zhang S . Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours. Eur J Surg Oncol. 2008; 35(8):826-32. DOI: 10.1016/j.ejso.2008.10.013. View

Passacquale G, Phinikaridou A, Warboys C, Cooper M, Lavin B, Alfieri A . Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration. Br J Pharmacol. 2015; 172(14):3548-64. PMC: 4507159. DOI: 10.1111/bph.13144. View

10.

Nelson E, Chang C, McDonnell D . Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab. 2014; 25(12):649-55. PMC: 4268141. DOI: 10.1016/j.tem.2014.10.001. View

11.

Baldwin A, Grueneberg D, Hellner K, Sawyer J, Grace M, Li W . Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proc Natl Acad Sci U S A. 2010; 107(28):12463-8. PMC: 2906576. DOI: 10.1073/pnas.1007462107. View

12.

Schuringa J, Wojtachnio K, HAGENS W, Vellenga E, Buys C, HOFSTRA R . MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene. 2001; 20(38):5350-8. DOI: 10.1038/sj.onc.1204715. View

13.

Mori Y, Olaru A, Cheng Y, Agarwal R, Yang J, Luvsanjav D . Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer. 2011; 18(4):465-78. PMC: 3464012. DOI: 10.1530/ERC-11-0083. View

14.

Hirsch H, Iliopoulos D, Struhl K . Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci U S A. 2013; 110(3):972-7. PMC: 3549132. DOI: 10.1073/pnas.1221055110. View

15.

Lee H, Choi H, Ha S, Lee K, Kwon Y . Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim Biophys Acta. 2013; 1835(2):170-9. DOI: 10.1016/j.bbcan.2012.12.007. View

16.

Nugent A, Kolpak A, Engle E . Human disorders of axon guidance. Curr Opin Neurobiol. 2012; 22(5):837-43. PMC: 3388149. DOI: 10.1016/j.conb.2012.02.006. View

17.

Liu J, Zhang Z, Li Z, Kong C . Clinical significance of UNC5B expression in bladder cancer. Tumour Biol. 2012; 34(4):2099-108. DOI: 10.1007/s13277-012-0532-y. View

18.

Ng K, Xu A, Cheng Q, Guo D, Lim Z, Kin-Wai Sun C . Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma. Mol Cancer. 2014; 13:196. PMC: 4149052. DOI: 10.1186/1476-4598-13-196. View

19.

Oliveras-Ferraros C, Vazquez-Martin A, Cuyas E, Corominas-Faja B, Rodriguez-Gallego E, Fernandez-Arroyo S . Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile. Cell Cycle. 2014; 13(7):1132-44. PMC: 4013163. DOI: 10.4161/cc.27982. View

20.

Algire C, Amrein L, Zakikhani M, Panasci L, Pollak M . Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer. 2010; 17(2):351-60. DOI: 10.1677/ERC-09-0252. View